Time
|
Session
|
7:45-8:15 am
|
Registration and Breakfast
|
8:15-8:30 am
|
Welcome and Introduction of Speakers
|
8:30-9:15 am
|
HIV Treatment Update: Divya Ahuja, MD
|
9:15-9:45 am
|
New ART Regimens: Scott Sutton, PharmD
|
9:45-10:30 am
|
PrEP for HIV: Kamla Sanasi-Bhola, MD
|
10:30-10:45 am
|
Break
|
10:45-11:45 am
|
Interactive Session: HIV Case Studies: HIV Speaker Panel; Moderator Divya Ahuja, MD
|
11:45-12:45 pm
|
Lunch
|
12:45-1:15 pm
|
HCV Screening, Diagnosing, & Staging: Eric Meissner, MD
|
1:15-2:15 pm
|
HCV Treatment Update: Divya Ahuja, MD
|
2:15-2:30 pm
|
Break
|
2:30-3:00 pm
|
Drug-Drug Interactions: Caroline Derrick, PharmD
|
3:00-4:00 pm
|
Interactive Session: HCV Case Studies: HCV Speaker Panel; Moderator Divya Ahuja, MD
|
4:00-4:15 pm
|
Evaluation, Adjourn
|
Date: Sep 22, 2018 07:45 AM - 04:15 PM
CE Hours
CE Units
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
Requirements for CE Credit
- Discuss updated treatment guidelines in HIV
- Summarize emerging developments in HIV including single tablet regimens
- Evaluate the role of the Primary Care Provider in HIV Co-management
Speaker(s)/Author(s)
Divya Ahuja, MD, MRCP (London)
|
Activity Number
0062-9999-18-162-L02-PCE Hours
- Review HIV treatment principles
- Discuss new antiretroviral regimens for HIV
Speaker(s)/Author(s)
Scott Sutton, PharmD
|
Activity Number
0062-9999-18-163-L02-PCE Hours
- Discuss current epidemiology & data supporting HIV PrEP
- Integrate PrEP into clinical practice
Speaker(s)/Author(s)
Kamla Devi Sanasi-Bhola, MD
|
Activity Number
0062-9999-18-164-L02-PCE Hours
- Recognize the clinical manifestations of HIV infection
Speaker(s)/Author(s)
Divya Ahuja, MD, MRCP (London)
|
Activity Number
0062-9999-18-165-L02-PCE Hours
- Discuss current epidemiology and testing recommendations for HCV infection
- Identify essential elements to include in the work-up of a chronically HCV infected patient
- Discuss the pros and cons of available modalities to evaluate and stage liver fibrosis
Speaker(s)/Author(s)
Eric Meissner, MD, PhD
|
Activity Number
0062-9999-18-166-L01-PCE Hours
- Discuss emerging developments in Hepatitis C
- Discuss appropriate treatment regimens for Hepatitis C
Speaker(s)/Author(s)
Divya Ahuja, MD, MRCP (London)
|
Activity Number
0062-9999-18-167-L01-PCE Hours
- Identify and assess the significance of agents that commonly interact with directly acting antivirals
- Discuss clinically relevant drug-drug interactions for the co-infected individual
Speaker(s)/Author(s)
Caroline Derrick, PharmD, BCPS, AAHIVP
|
Activity Number
0062-9999-18-168-L01-PCE Hours
- Recognize the clinical manifestations of HCV infection
Speaker(s)/Author(s)
Divya Ahuja, MD, MRCP (London)
|